Annual EBITDA
$1.92 M
+$25.10 M+108.29%
31 December 2023
Summary:
Journey Medical annual earnings before interest, taxes, depreciation & amortization is currently $1.92 million, with the most recent change of +$25.10 million (+108.29%) on 31 December 2023. During the last 3 years, it has fallen by -$7.45 million (-79.49%). DERM annual EBITDA is now -79.49% below its all-time high of $9.37 million, reached on 31 December 2020.DERM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$795.00 K
+$1.16 M+59.42%
30 September 2024
Summary:
Journey Medical quarterly earnings before interest, taxes, depreciation & amortization is currently -$795.00 thousand, with the most recent change of +$1.16 million (+59.42%) on 30 September 2024. Over the past year, it has dropped by -$18.78 million (-104.42%). DERM quarterly EBITDA is now -104.42% below its all-time high of $17.99 million, reached on 30 September 2023.DERM Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$12.97 M
-$18.78 M-322.95%
30 September 2024
Summary:
Journey Medical TTM earnings before interest, taxes, depreciation & amortization is currently -$12.97 million, with the most recent change of -$18.78 million (-322.95%) on 30 September 2024. Over the past year, it has dropped by -$7.28 million (-127.97%). DERM TTM EBITDA is now -276.37% below its all-time high of $7.35 million, reached on 31 March 2021.DERM TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DERM EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +108.3% | -104.4% | -128.0% |
| 3 y3 years | -79.5% | +93.4% | +35.0% |
| 5 y5 years | +100.9% | - | - |
DERM EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -79.5% | +105.9% | -104.4% | +93.4% | -322.9% | +61.6% |
| 5 y | 5 years | -79.5% | +100.9% | -104.4% | +94.0% | -276.4% | +61.6% |
| alltime | all time | -79.5% | +100.7% | -104.4% | +94.0% | -276.4% | +61.6% |
Journey Medical EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$795.00 K(-59.4%) | -$12.97 M(-323.0%) |
| June 2024 | - | -$1.96 M(-78.4%) | $5.82 M(+362.3%) |
| Mar 2024 | - | -$9.06 M(+684.2%) | $1.26 M(-34.5%) |
| Dec 2023 | $1.92 M(-108.3%) | -$1.16 M(-106.4%) | $1.92 M(-133.8%) |
| Sept 2023 | - | $17.99 M(-376.0%) | -$5.69 M(-82.3%) |
| June 2023 | - | -$6.52 M(-22.4%) | -$32.15 M(+1.3%) |
| Mar 2023 | - | -$8.39 M(-4.2%) | -$31.73 M(+36.9%) |
| Dec 2022 | -$23.18 M(-29.3%) | -$8.76 M(+3.4%) | -$23.18 M(-0.2%) |
| Sept 2022 | - | -$8.47 M(+38.9%) | -$23.22 M(-13.1%) |
| June 2022 | - | -$6.10 M(-4060.4%) | -$26.72 M(-21.0%) |
| Mar 2022 | - | $154.00 K(-101.7%) | -$33.81 M(+3.2%) |
| Dec 2021 | -$32.77 M | -$8.80 M(-26.4%) | -$32.77 M(+64.2%) |
| Sept 2021 | - | -$11.97 M(-9.3%) | -$19.96 M(+170.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | -$13.19 M(-1208.2%) | -$7.38 M(-200.3%) |
| Mar 2021 | - | $1.19 M(-70.3%) | $7.35 M(+19.3%) |
| Dec 2020 | $9.37 M(+43.6%) | $4.00 M(+548.1%) | $6.16 M(+185.7%) |
| Sept 2020 | - | $618.00 K(-59.8%) | $2.16 M(+40.2%) |
| June 2020 | - | $1.54 M | $1.54 M |
| Dec 2019 | $6.52 M(-103.2%) | - | - |
| Dec 2018 | -$205.54 M(-30.3%) | - | - |
| Dec 2017 | -$294.78 M(+231.4%) | - | - |
| Dec 2016 | -$88.96 M(+12.9%) | - | - |
| Dec 2015 | -$78.80 M(+149.2%) | - | - |
| Dec 2014 | -$31.63 M(+41.7%) | - | - |
| Dec 2013 | -$22.32 M(+10.3%) | - | - |
| Dec 2012 | -$20.24 M | - | - |
FAQ
- What is Journey Medical annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Journey Medical?
- What is Journey Medical annual EBITDA year-on-year change?
- What is Journey Medical quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Journey Medical?
- What is Journey Medical quarterly EBITDA year-on-year change?
- What is Journey Medical TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Journey Medical?
- What is Journey Medical TTM EBITDA year-on-year change?
What is Journey Medical annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of DERM is $1.92 M
What is the all time high annual EBITDA for Journey Medical?
Journey Medical all-time high annual earnings before interest, taxes, depreciation & amortization is $9.37 M
What is Journey Medical annual EBITDA year-on-year change?
Over the past year, DERM annual earnings before interest, taxes, depreciation & amortization has changed by +$25.10 M (+108.29%)
What is Journey Medical quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of DERM is -$795.00 K
What is the all time high quarterly EBITDA for Journey Medical?
Journey Medical all-time high quarterly earnings before interest, taxes, depreciation & amortization is $17.99 M
What is Journey Medical quarterly EBITDA year-on-year change?
Over the past year, DERM quarterly earnings before interest, taxes, depreciation & amortization has changed by -$18.78 M (-104.42%)
What is Journey Medical TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of DERM is -$12.97 M
What is the all time high TTM EBITDA for Journey Medical?
Journey Medical all-time high TTM earnings before interest, taxes, depreciation & amortization is $7.35 M
What is Journey Medical TTM EBITDA year-on-year change?
Over the past year, DERM TTM earnings before interest, taxes, depreciation & amortization has changed by -$7.28 M (-127.97%)